JP2014525420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525420A5 JP2014525420A5 JP2014527483A JP2014527483A JP2014525420A5 JP 2014525420 A5 JP2014525420 A5 JP 2014525420A5 JP 2014527483 A JP2014527483 A JP 2014527483A JP 2014527483 A JP2014527483 A JP 2014527483A JP 2014525420 A5 JP2014525420 A5 JP 2014525420A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- salt
- alkyl
- formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 17
- 239000011780 sodium chloride Substances 0.000 claims 17
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000005843 halogen group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- 125000004663 dialkyl amino group Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- -1 nitro, hydroxy Chemical group 0.000 claims 3
- 125000006618 5- to 10-membered aromatic heterocyclic group Chemical group 0.000 claims 2
- 125000004429 atoms Chemical group 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000001548 androgenic Effects 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011001477 | 2011-08-31 | ||
| CNPCT/CN2011/001477 | 2011-08-31 | ||
| CN2012001044 | 2012-08-06 | ||
| CNPCT/CN2012/001044 | 2012-08-06 | ||
| PCT/CN2012/080753 WO2013029548A1 (en) | 2011-08-31 | 2012-08-30 | Quinolone compound |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015168524A Division JP6039025B2 (ja) | 2011-08-31 | 2015-08-28 | キノロン化合物 |
| JP2016181129A Division JP2017039733A (ja) | 2011-08-31 | 2016-09-16 | キノロン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014525420A JP2014525420A (ja) | 2014-09-29 |
| JP2014525420A5 true JP2014525420A5 (US07585860-20090908-C00112.png) | 2015-10-15 |
| JP6106174B2 JP6106174B2 (ja) | 2017-03-29 |
Family
ID=47755336
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527483A Active JP6106174B2 (ja) | 2011-08-31 | 2012-08-30 | キノロン化合物 |
| JP2015168524A Active JP6039025B2 (ja) | 2011-08-31 | 2015-08-28 | キノロン化合物 |
| JP2016181129A Pending JP2017039733A (ja) | 2011-08-31 | 2016-09-16 | キノロン化合物 |
| JP2018087535A Pending JP2018150324A (ja) | 2011-08-31 | 2018-04-27 | キノロン化合物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015168524A Active JP6039025B2 (ja) | 2011-08-31 | 2015-08-28 | キノロン化合物 |
| JP2016181129A Pending JP2017039733A (ja) | 2011-08-31 | 2016-09-16 | キノロン化合物 |
| JP2018087535A Pending JP2018150324A (ja) | 2011-08-31 | 2018-04-27 | キノロン化合物 |
Country Status (29)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2845551T3 (es) * | 2011-02-01 | 2021-07-27 | Emergent Product Dev Gaithersburg Inc | 4-oxoquinolizinas antimicrobianas |
| SG10201505811QA (en) * | 2011-08-31 | 2015-09-29 | Otsuka Pharma Co Ltd | Quinolone compound |
| CA2903881C (en) * | 2013-03-15 | 2021-05-18 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
| AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| ES2635560T3 (es) | 2013-07-08 | 2017-10-04 | Incyte Holdings Corporation | Heterociclos tricíclicos como inhibidores de la proteína NET |
| CN104513253A (zh) | 2013-10-01 | 2015-04-15 | 南京波尔泰药业科技有限公司 | 用于治疗增殖性疾病的大环化合物 |
| US9399640B2 (en) | 2013-11-26 | 2016-07-26 | Incyte Corporation | Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors |
| WO2015081189A1 (en) | 2013-11-26 | 2015-06-04 | Incyte Corporation | Bicyclic heterocycles as bet protein inhibitors |
| WO2015095492A1 (en) | 2013-12-19 | 2015-06-25 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
| NZ763737A (en) | 2014-04-23 | 2023-04-28 | Incyte Holdings Corp | 1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins |
| US9527864B2 (en) | 2014-09-15 | 2016-12-27 | Incyte Corporation | Tricyclic heterocycles as BET protein inhibitors |
| DK3226858T3 (da) | 2014-12-04 | 2021-03-29 | Procomcure Biotech Gmbh | Imidazolbaserede antimikrobielle stoffer |
| US10314820B2 (en) | 2014-12-04 | 2019-06-11 | Procomcure Biotech Gmbh | Imidazole-based heterocyclic compounds |
| KR102123365B1 (ko) * | 2015-07-28 | 2020-06-16 | 바이옴 테라퓨틱스 리미티드 | 항박테리아 치료제 및 예방제 |
| WO2017075377A1 (en) | 2015-10-29 | 2017-05-04 | Incyte Corporation | Amorphous solid form of a bet protein inhibitor |
| US10226464B2 (en) * | 2015-12-29 | 2019-03-12 | ImmuneTarget, Inc. | Small molecule NF-κB inhibitors |
| US10189832B2 (en) | 2016-06-20 | 2019-01-29 | Incyte Corporation | Crystalline solid forms of a BET inhibitor |
| WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
| KR102537749B1 (ko) | 2017-06-14 | 2023-05-26 | 산요 시키소 가부시키가이샤 | 안료 분산체 및 그것을 포함하는 착색 조성물 |
| CN108191889B (zh) * | 2018-01-11 | 2019-06-07 | 河南大学 | 1-(n-氧氟沙星酰胺基)-6-氟-7-哌嗪萘啶酮酸化合物及其制备方法和应用 |
| CN107964020B (zh) * | 2018-01-11 | 2019-07-05 | 河南大学 | 1-(n-左氧氟沙星酰胺基)-6-氟-7-哌嗪萘啶酮酸化合物及其制备方法和应用 |
| JP2021534156A (ja) | 2018-08-13 | 2021-12-09 | 大塚製薬株式会社 | 新規炎症性腸疾患治療剤 |
| WO2020163816A1 (en) * | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Quinolin-4-one and 4(1h)-cinnolinone compounds and methods of using same |
| CN110563645B (zh) * | 2019-06-14 | 2021-03-30 | 山东省联合农药工业有限公司 | 一种喹诺酮类化合物及其制备方法和应用 |
| CN112624970B (zh) * | 2019-09-24 | 2022-10-28 | 南开大学 | 8位芳基取代喹啉氮氧化物在抗植物病毒及杀菌方面的应用 |
| CN113264878B (zh) * | 2019-11-11 | 2022-05-27 | 山东畜牧兽医职业学院 | 一种用于畜牧业治疗耐药性微生物菌的化合物的制备方法 |
| JP2023012557A (ja) | 2020-02-10 | 2023-01-26 | 大塚製薬株式会社 | 新規肝性脳症治療剤 |
| JP2023012559A (ja) | 2020-02-10 | 2023-01-26 | 大塚製薬株式会社 | 新規炎症性疾患治療剤 |
| JP2023012558A (ja) | 2020-02-10 | 2023-01-26 | 大塚製薬株式会社 | 腸内細菌叢構成比率調整剤 |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| WO2023208172A1 (en) * | 2022-04-29 | 2023-11-02 | Beigene , Ltd. | Substituted 7- (pyrimidin-4-yl) quinolin-4 (1h) -one compounds as cyclin dependent kinase inhibitors |
| WO2024012421A1 (en) * | 2022-07-11 | 2024-01-18 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical compositions comprising a quinolone compound for irritable bowel syndrome |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5781486A (en) * | 1980-11-10 | 1982-05-21 | Otsuka Pharmaceut Co Ltd | Benzo(ij)quinolidine-2-carboxylic acid derivative |
| JPS5872589A (ja) * | 1981-10-28 | 1983-04-30 | Dai Ichi Seiyaku Co Ltd | ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体 |
| US4443447A (en) | 1982-10-25 | 1984-04-17 | Riker Laboratories, Inc. | Phenyl-substituted tricyclic antibacterial agents |
| ZA859283B (en) | 1984-12-06 | 1987-07-29 | Pfizer | Substituted dihydroquinolone carboxylic acids and anti-bacterial compositions containing them |
| US4623650A (en) * | 1984-12-06 | 1986-11-18 | Pfizer Inc. | Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids |
| US4636506A (en) * | 1984-12-06 | 1987-01-13 | Pfizer, Inc. | 7-heterocyclic-1,4-dihydroquinolones |
| US4797490A (en) * | 1984-12-06 | 1989-01-10 | Pfizer Inc. | Process for the preparation of 3-(2'-fluorophenyl)pyridine |
| JPS62228063A (ja) * | 1985-12-27 | 1987-10-06 | Sankyo Co Ltd | キノリンカルボン酸誘導体 |
| IT1197841B (it) * | 1986-10-14 | 1988-12-06 | Mediolanum Farmaceutici Srl | Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione |
| US4929613A (en) | 1987-08-26 | 1990-05-29 | Warner-Lambert Company | Antibacterial agents |
| US5081254A (en) | 1987-08-26 | 1992-01-14 | Warner-Lambert Company | Antibacterial agents |
| US5075319A (en) * | 1987-09-08 | 1991-12-24 | Sterling Drug Inc. | Pyridinyl-quinolone compounds, their preparation and use |
| US4839355A (en) * | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
| WO1989005643A1 (en) * | 1987-12-18 | 1989-06-29 | Pfizer Inc. | Heterocyclic-substituted quinoline-carboxylic acids |
| DE3816119A1 (de) * | 1988-05-11 | 1989-11-23 | Bayer Ag | 7-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
| JPH0366301A (ja) | 1989-08-03 | 1991-03-22 | Asahi Corp | 靴底射出成形金型 |
| KR910009333B1 (ko) * | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| JP2613139B2 (ja) * | 1990-07-19 | 1997-05-21 | エスエス製薬 株式会社 | キノロンカルボン酸誘導体 |
| US5308843A (en) * | 1990-09-11 | 1994-05-03 | Sterling Drug Inc. | Method of inhibiting mammalian topoisomerase II and malignant cell growth in mammals, with substituted (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4 ]-benzoxazine(and-benzothiazine)-6-carboxylic acids |
| CA2099591C (en) | 1990-12-05 | 2002-11-12 | Rajeshwar Singh | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents |
| NZ290946A (en) | 1994-08-12 | 1997-12-19 | Toyama Chemical Co Ltd | Quinolone- or naphthyridone-carboxylic acid derivatives |
| EP0994878B1 (en) | 1997-06-26 | 2001-11-28 | Dong Wha Pharmaceutical Industrial Co. Ltd. | Quinolone carboxylic acid derivatives |
| AU8128898A (en) | 1997-07-16 | 1999-02-10 | Eisai Co. Ltd. | Antibiotics containing indole derivatives |
| JP4370002B2 (ja) * | 1997-08-08 | 2009-11-25 | 富山化学工業株式会社 | キノロンカルボン酸誘導体またはその塩 |
| TW593308B (en) | 1997-10-27 | 2004-06-21 | Toyama Chemical Co Ltd | Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| DK1070713T3 (da) | 1998-04-06 | 2006-12-27 | Toyama Chemical Co Ltd | Quinoloncarboxylsyrederivater eller salte deraf |
| JP2000229946A (ja) * | 1998-12-10 | 2000-08-22 | Toyama Chem Co Ltd | キノロンカルボン酸の製造法およびその中間体 |
| JP4621356B2 (ja) * | 1999-02-05 | 2011-01-26 | 富山化学工業株式会社 | 三環キノロンカルボン酸誘導体またはその塩 |
| US20020049223A1 (en) * | 1999-11-05 | 2002-04-25 | Elmore Steven W. | Quinoline and naphthyridine carboxylic acid antibacterials |
| DE10026903A1 (de) * | 2000-06-03 | 2002-01-10 | Cpc Cellular Process Chemistry | Verfahren zur Herstellung von Chinolon-3-carbonsäuren |
| WO2002009758A2 (en) * | 2000-08-01 | 2002-02-07 | Wockhardt Limited | Inhibitors of cellular efflux pumps of microbes |
| JP2003104988A (ja) * | 2001-09-28 | 2003-04-09 | Sato Pharmaceutical Co Ltd | 抗菌剤として有用なキノロン誘導体 |
| US7012144B2 (en) | 2001-12-31 | 2006-03-14 | Korea Research Institute Of Chemical Technology | Quinolone carboxylic acid derivatives |
| JP3885679B2 (ja) * | 2002-06-28 | 2007-02-21 | 株式会社日立製作所 | 電子機器 |
| US20070224282A1 (en) * | 2005-03-28 | 2007-09-27 | Toyama Chemical Co., Ltd. | Fine Dispersion of Sparingly Soluble Drug and Process for Producing the Same |
| WO2007094077A1 (ja) * | 2006-02-17 | 2007-08-23 | Kyushu University | 微生物検出法及び微生物検出キット |
| CN101168541A (zh) * | 2006-10-26 | 2008-04-30 | 孙飘扬 | 喹诺酮羧酸类衍生物及其制备方法和药物用途 |
| US8124623B2 (en) * | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
| US20090270379A1 (en) * | 2008-04-23 | 2009-10-29 | Macielag Mark J | Quinolone derivatives useful as antibacterial agents |
| EP2177214A1 (en) * | 2008-10-17 | 2010-04-21 | Ferrer Internacional, S.A. | Solid Oral Dosage Forms and Uses |
| SG10201505811QA (en) * | 2011-08-31 | 2015-09-29 | Otsuka Pharma Co Ltd | Quinolone compound |
-
2012
- 2012-08-30 SG SG10201505811QA patent/SG10201505811QA/en unknown
- 2012-08-30 TW TW101131516A patent/TWI606044B/zh active
- 2012-08-30 NO NO12827305A patent/NO2751083T3/no unknown
- 2012-08-30 TW TW106102905A patent/TW201718506A/zh unknown
- 2012-08-30 SG SG10201606932TA patent/SG10201606932TA/en unknown
- 2012-08-30 KR KR1020137018036A patent/KR101560073B1/ko active IP Right Grant
- 2012-08-30 AU AU2012303954A patent/AU2012303954B2/en active Active
- 2012-08-30 CN CN201280041352.0A patent/CN103764631B/zh active Active
- 2012-08-30 BR BR112014000665A patent/BR112014000665B8/pt not_active IP Right Cessation
- 2012-08-30 KR KR1020147031410A patent/KR20140139132A/ko not_active Application Discontinuation
- 2012-08-30 PT PT128273059T patent/PT2751083T/pt unknown
- 2012-08-30 SI SI201231233T patent/SI2751083T1/en unknown
- 2012-08-30 LT LTEP12827305.9T patent/LT2751083T/lt unknown
- 2012-08-30 EA EA201490530A patent/EA030867B1/ru not_active IP Right Cessation
- 2012-08-30 CA CA2845459A patent/CA2845459C/en active Active
- 2012-08-30 DK DK12827305.9T patent/DK2751083T3/en active
- 2012-08-30 MY MYPI2014000509A patent/MY165004A/en unknown
- 2012-08-30 EA EA201890098A patent/EA034787B1/ru not_active IP Right Cessation
- 2012-08-30 CN CN201510404261.4A patent/CN105017151B/zh active Active
- 2012-08-30 PL PL12827305T patent/PL2751083T3/pl unknown
- 2012-08-30 TW TW105116079A patent/TWI583680B/zh active
- 2012-08-30 ES ES12827305.9T patent/ES2660973T3/es active Active
- 2012-08-30 EP EP17202139.6A patent/EP3318557A3/en not_active Withdrawn
- 2012-08-30 EP EP12827305.9A patent/EP2751083B1/en active Active
- 2012-08-30 SG SG2014004162A patent/SG2014004162A/en unknown
- 2012-08-30 JP JP2014527483A patent/JP6106174B2/ja active Active
- 2012-08-30 HU HUE12827305A patent/HUE036301T2/hu unknown
- 2012-08-30 CN CN201610052007.7A patent/CN105712976A/zh active Pending
- 2012-08-30 MX MX2014002338A patent/MX371361B/es active IP Right Grant
- 2012-08-30 AR ARP120103215A patent/AR087747A1/es unknown
- 2012-08-30 WO PCT/CN2012/080753 patent/WO2013029548A1/en active Application Filing
- 2012-08-30 KR KR1020147017145A patent/KR101996697B1/ko active IP Right Grant
-
2014
- 2014-01-20 IL IL230559A patent/IL230559B/en active IP Right Grant
- 2014-02-27 MX MX2019010100A patent/MX2019010100A/es unknown
- 2014-02-28 US US14/193,656 patent/US9067887B2/en not_active Expired - Fee Related
- 2014-03-27 CO CO14065672A patent/CO6920292A2/es active IP Right Grant
- 2014-03-28 ZA ZA2014/02326A patent/ZA201402326B/en unknown
- 2014-12-08 HK HK14112301.3A patent/HK1198828A1/xx not_active IP Right Cessation
-
2015
- 2015-05-11 US US14/709,261 patent/US9440951B2/en active Active
- 2015-08-28 JP JP2015168524A patent/JP6039025B2/ja active Active
-
2016
- 2016-04-19 HK HK16104451.6A patent/HK1216528A1/zh unknown
- 2016-08-01 US US15/225,130 patent/US20160340314A1/en not_active Abandoned
- 2016-09-16 JP JP2016181129A patent/JP2017039733A/ja active Pending
- 2016-12-22 HK HK16114584A patent/HK1226077A1/zh unknown
-
2017
- 2017-06-02 AU AU2017203756A patent/AU2017203756B2/en active Active
- 2017-08-30 US US15/691,216 patent/US20170362180A1/en not_active Abandoned
-
2018
- 2018-03-14 CY CY20181100309T patent/CY1120066T1/el unknown
- 2018-03-22 HR HRP20180483TT patent/HRP20180483T1/hr unknown
- 2018-04-27 JP JP2018087535A patent/JP2018150324A/ja active Pending
- 2018-09-12 HK HK18111686.6A patent/HK1252389A1/zh unknown
- 2018-11-09 US US16/185,437 patent/US20190077762A1/en not_active Abandoned
-
2019
- 2019-10-22 US US16/659,987 patent/US20200055823A1/en not_active Abandoned
-
2020
- 2020-10-19 US US17/073,513 patent/US20210032207A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525420A5 (US07585860-20090908-C00112.png) | ||
| HRP20180483T1 (hr) | Spoj kinolona | |
| JP2016506960A5 (US07585860-20090908-C00112.png) | ||
| TN2012000608A1 (en) | Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof | |
| JP2016506962A5 (US07585860-20090908-C00112.png) | ||
| JP2014510147A5 (US07585860-20090908-C00112.png) | ||
| JP2016525075A5 (US07585860-20090908-C00112.png) | ||
| MY192521A (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
| UA108087C2 (uk) | Тверді форми n-(4-(7-азабіцикло[2.2.1]гептан-7-іл)-2-(трифторметил)феніл)-4-оксо-5-(трифторметил)-1,4-дигідрохінолін-3-карбоксаміду | |
| JP2015500843A5 (US07585860-20090908-C00112.png) | ||
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| MX2014000359A (es) | Metodos plaguicidas que utilizan compuestos de 3 - piridin tiazol sustituido y derivados para combatir las plagas de animales ii. | |
| JP2014507464A5 (US07585860-20090908-C00112.png) | ||
| PH12015501585A1 (en) | Manufacturing process for pyrimidine derivatives | |
| UA109792C2 (uk) | Індоли як противірусні агенти відносно респіраторного синтиціального вірусу | |
| TN2012000609A1 (en) | Indolizine derivatives, process for the preparation thereof and therapeutic use thereof | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| MX2014002833A (es) | Derivados fungicidas de 3-fenil[(heterociclilmetoxi)imino]metil}-1 ,2,4-oxadiazol-5(4h)-ona sustituidos en 4. | |
| MX2021006544A (es) | Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer. | |
| MX344276B (es) | Compuesto de piperidina novedoso o sal del mismo. | |
| JP2014526533A5 (US07585860-20090908-C00112.png) | ||
| JP2016540803A5 (US07585860-20090908-C00112.png) | ||
| JP2016528273A5 (US07585860-20090908-C00112.png) | ||
| UA111210C2 (uk) | Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом | |
| JP2015500842A5 (US07585860-20090908-C00112.png) |
